EcoDrugPlus

Receptor Interacting Serine/threonine Kinase 1

Ensembl ID : ENSVPAG00000009747
Gene Symbol: RIPK1
1 Cross references
197 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSVPAG00000009206
Gene Symbol: RARB
1 Cross references
450 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSVPAG00000004578
Gene Symbol: RXRG
1 Cross references
273 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSVPAG00000009466
Gene Symbol: RPL22
1 Cross references
95 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSVPAG00000005694
Gene Symbol: RPL23
1 Cross references
210 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSVPAG00000012246
Gene Symbol: RPL24
3 Cross references
301 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSVPAG00000000279
Gene Symbol: RPL26
1 Cross references
200 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSVPAG00000002574
Gene Symbol: RPL27
1 Cross references
206 Possible Orthologues:

Ribosomal Protein L29

Ensembl ID : ENSVPAG00000001282
Gene Symbol: RPL29
1 Cross references
258 Possible Orthologues:

Ribosomal Protein L3

Ensembl ID : ENSVPAG00000009706
Gene Symbol: RPL3
1 Cross references
244 Possible Orthologues:

Ribosomal Protein L30

Ensembl ID : ENSVPAG00000008273
Gene Symbol: RPL30
1 Cross references
212 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSVPAG00000009263
Gene Symbol: RPL35
1 Cross references
270 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).